PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.580.04 (-0.71%)
5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.36%
Revenue growth above 1.5x UPM.HE's 3.07%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
-7.00%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-22.32%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-22.32%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-22.45%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-20.00%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-20.00%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-3.06%
Share reduction while UPM.HE is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-3.06%
Reduced diluted shares while UPM.HE is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
20.20%
OCF growth under 50% of UPM.HE's 58.17%. Michael Burry might suspect questionable revenue recognition or rising costs.
12.87%
FCF growth under 50% of UPM.HE's 70.75%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
-15.64%
Negative 10Y revenue/share CAGR while UPM.HE stands at 5.18%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-13.13%
Negative 5Y CAGR while UPM.HE stands at 1.70%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
4.03%
3Y revenue/share CAGR above 1.5x UPM.HE's 1.64%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
272.69%
10Y OCF/share CAGR under 50% of UPM.HE's 594.16%. Michael Burry would worry about a persistent underperformance in cash creation.
926.17%
5Y OCF/share CAGR above 1.5x UPM.HE's 287.70%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
-31.90%
Negative 3Y OCF/share CAGR while UPM.HE stands at 1.58%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
141.86%
Net income/share CAGR at 75-90% of UPM.HE's 183.78%. Bill Ackman would press for strategic moves to boost long-term earnings.
100.00%
5Y net income/share CAGR at 50-75% of UPM.HE's 133.57%. Martin Whitman might see a shortfall in operational efficiency or brand power.
-20.00%
Negative 3Y CAGR while UPM.HE is 68.18%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
22.37%
5Y equity/share CAGR 1.25-1.5x UPM.HE's 17.50%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
22.73%
3Y equity/share CAGR above 1.5x UPM.HE's 14.46%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
219.32%
5Y dividend/share CAGR above 1.5x UPM.HE's 91.42%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
98.48%
3Y dividend/share CAGR above 1.5x UPM.HE's 64.40%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
8.31%
Our AR growth while UPM.HE is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-3.36%
Inventory is declining while UPM.HE stands at 7.29%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-6.39%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
6.92%
Positive BV/share change while UPM.HE is negative. John Neff sees a clear edge over a competitor losing equity.
-21.68%
We’re deleveraging while UPM.HE stands at 26.92%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
6.22%
SG&A growth of 6.22% while UPM.HE is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.